Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Arcadia Biosciences, Inc. RKDA

Full chart Compare
Set alert

Price alert · RKDA

All alert types
0.16 USD 0.00 (-0.58%)

Nov 3, 2026, 3:26 PM EST

0.1429 Day range 0.1599
0.111 52-week range 4.18
YTD
-92.17%
1 year
-95.70%

Financial health

Altman Z-Score

-73.90 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 3

Valuation

P/E -1.2×
FY 2016: -2.1×FY 2017: -0.8×FY 2018: -0.9×FY 2019: -1.2×FY 2020: -4.2×FY 2021: -1.4×FY 2022: -0.4×FY 2023: -0.3×FY 2024: -1.1×FY 2025: -1.2×
FY 2016 5y median -1.1× FY 2025
P/S 0.6×
FY 2016: 12.8×FY 2017: 2.9×FY 2018: 8.2×FY 2019: 29.8×FY 2020: 3.1×FY 2021: 3.3×FY 2022: 0.9×FY 2023: 0.9×FY 2024: 1.6×FY 2025: 0.6×
FY 2016 5y median 0.9× FY 2025
P/B 0.7×
FY 2016: 1.8×FY 2017: 1.5×FY 2018: 0.9×FY 2019: 4.5×FY 2020: 0.9×FY 2021: 0.7×FY 2022: 0.3×FY 2023: 0.3×FY 2024: 1.3×FY 2025: 0.7×
FY 2016 5y median 0.7× FY 2025
P/FCF -0.6×
FY 2016: -2.4×FY 2017: -0.8×FY 2018: -0.9×FY 2019: -1.9×FY 2020: -0.8×FY 2021: -0.8×FY 2022: -0.5×FY 2023: -0.3×FY 2024: -0.8×FY 2025: -0.6×
FY 2016 5y median -0.6× FY 2025
EV/EBITDA -1.1×
FY 2016: -3.6×FY 2017: -0.2×FY 2018: 0.0×FY 2019: -1.0×FY 2020: -3.8×FY 2021: 0.1×FY 2022: 0.8×FY 2023: 0.3×FY 2024: -0.6×FY 2025: -1.1×
FY 2016 5y median 0.1× FY 2025
EV/Sales 0.5×
FY 2016: 20.1×FY 2017: 0.7×FY 2018: -0.0×FY 2019: 24.5×FY 2020: 2.6×FY 2021: -0.5×FY 2022: -1.6×FY 2023: -0.4×FY 2024: 0.8×FY 2025: 0.5×
FY 2016 5y median -0.4× FY 2025
FCF Yield -175.0%
FY 2016: -42.3%FY 2017: -118.4%FY 2018: -116.3%FY 2019: -53.6%FY 2020: -129.2%FY 2021: -121.4%FY 2022: -216.2%FY 2023: -395.2%FY 2024: -119.5%FY 2025: -175.0%
FY 2016 5y median -175.0% FY 2025

Profitability

Gross Margin 36.2%
FY 2016: 71.9%FY 2017: 93.0%FY 2018: 54.8%FY 2019: 24.3%FY 2020: 35.3%FY 2021: -28.4%FY 2022: 17.8%FY 2023: 51.2%FY 2024: 41.3%FY 2025: 36.2%
FY 2016 5y median 36.2% FY 2025
Operating Margin -205.7%
FY 2016: -584.1%FY 2017: -355.6%FY 2018: -1152.3%FY 2019: -1657.9%FY 2020: -159.0%FY 2021: -524.0%FY 2022: -188.8%FY 2023: -137.0%FY 2024: -72.3%FY 2025: -205.7%
FY 2016 5y median -188.8% FY 2025
Net Margin -48.1%
FY 2016: -615.6%FY 2017: -390.1%FY 2018: -920.8%FY 2019: -2464.1%FY 2020: -57.9%FY 2021: -216.2%FY 2022: -207.3%FY 2023: -313.9%FY 2024: -139.5%FY 2025: -48.1%
FY 2016 5y median -207.3% FY 2025
ROE -56.5%
FY 2016: -88.4%FY 2017: -196.2%FY 2018: -105.2%FY 2019: -373.8%FY 2020: -16.8%FY 2021: -47.1%FY 2022: -73.1%FY 2023: -108.9%FY 2024: -113.1%FY 2025: -56.5%
FY 2016 5y median -73.1% FY 2025
ROIC -222.8%
FY 2016: -34.8%FY 2017: -109.7%FY 2018: -80.4%FY 2019: -70.5%FY 2020: -29.2%FY 2021: -88.9%FY 2022: -54.5%FY 2023: -36.0%FY 2024: -32.8%FY 2025: -222.8%
FY 2016 5y median -54.5% FY 2025
ROA -35.7%
FY 2016: -34.7%FY 2017: -94.8%FY 2018: -56.1%FY 2019: -88.4%FY 2020: -9.8%FY 2021: -33.4%FY 2022: -53.2%FY 2023: -71.0%FY 2024: -52.1%FY 2025: -35.7%
FY 2016 5y median -52.1% FY 2025

Growth (YoY)

Revenue -3.7%
FY 2016: -41.1%FY 2017: 26.3%FY 2018: -63.6%FY 2019: -20.2%FY 2020: 587.3%FY 2021: -15.6%FY 2022: 9.4%FY 2023: -40.0%FY 2024: 13.3%FY 2025: -3.7%
FY 2016 FY 2025
Operating Income -174.0%
FY 2016: -19.6%FY 2017: 23.1%FY 2018: -17.8%FY 2019: -14.9%FY 2020: 34.1%FY 2021: -178.0%FY 2022: 60.6%FY 2023: 56.4%FY 2024: 40.2%FY 2025: -174.0%
FY 2016 FY 2025
EPS (diluted) 66.9%
FY 2016: 29.7%FY 2017: 17.7%FY 2018: 50.9%FY 2019: -26.8%FY 2020: 86.7%FY 2021: -25.3%FY 2022: 14.1%FY 2023: 56.6%FY 2024: 54.3%FY 2025: 66.9%
FY 2016 FY 2025
Free Cash Flow 50.9%
FY 2016: -13.3%FY 2017: 18.8%FY 2018: 1.2%FY 2019: -34.5%FY 2020: -74.3%FY 2021: 17.4%FY 2022: 47.7%FY 2023: -8.9%FY 2024: 37.0%FY 2025: 50.9%
FY 2016 FY 2025

Financial Health

Current Ratio 3.1×
FY 2016: 16.7×FY 2017: 4.3×FY 2018: 7.5×FY 2019: 5.0×FY 2020: 5.0×FY 2021: 7.0×FY 2022: 6.0×FY 2023: 4.2×FY 2024: 3.6×FY 2025: 3.1×
FY 2016 5y median 4.2× FY 2025
Quick Ratio 2.5×
FY 2016: 16.6×FY 2017: 4.2×FY 2018: 7.4×FY 2019: 4.7×FY 2020: 4.4×FY 2021: 6.1×FY 2022: 5.5×FY 2023: 3.6×FY 2024: 3.3×FY 2025: 2.5×
FY 2016 5y median 3.6× FY 2025
Debt / Equity 0.0×
FY 2016: 1.1×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.3×FY 2020: 0.3×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.1×
FY 2016: -1.3×FY 2017: 0.6×FY 2018: 0.9×FY 2019: 0.2×FY 2020: 0.9×FY 2021: 0.9×FY 2022: 1.3×FY 2023: 1.0×FY 2024: 0.6×FY 2025: 0.1×
FY 2016 5y median 0.9× FY 2025
Interest Coverage 0.0×
FY 2016: -14.1×FY 2017: -19.2×FY 2018: -6.6×FY 2019: -3876×FY 2020: -272×FY 2021: -1776×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31